+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Nanopore Sequencing Market Outlook 2026-2034: by Technology (Biological Nanopores, Solid-state Nanopores, Hybrid Nanopores), Product Type, Application, End User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242800
UP TO OFF until Jan 01st 2027
The Nanopore Sequencing Market is estimated at US$449.6 million in 2026 and is projected to grow at a CAGR of 9.4% to reach US$922.5 million by 2034.

Market Overview

The Nanopore Sequencing Market covers sequencing technologies that analyze nucleic acids through nanopore based signal detection for rapid, flexible, and real time genomic analysis.

Relevant uses and settings include genomics research, pathogen surveillance, clinical sequencing, field testing, agricultural genomics, and academic biology programs. Commercial considerations include accuracy expectations, data interpretation complexity, workflow standardization, and competition from other sequencing approaches with established lab familiarity.

Market Segmentation

By Technology

  • Biological Nanopores
  • Solid-state Nanopores
  • Hybrid Nanopores

By Product Type

  • Instruments
  • Consumables
  • Software & Services

By Application

  • Clinical Diagnostics
  • Human Genomics
  • Oncology & Precision Medicine
  • Plant & Animal Genomics
  • Infectious-disease Surveillance
  • Drug Development & Pharmacogenomics
  • Food Safety & Environmental Monitoring

By End User

  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Public-health Agencies
  • Agrigenomics & Veterinary Labs

Key Companies Analysed

  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Illumina
  • Thermo Fisher Scientific
  • Roche
  • QIAGEN
  • BGI Genomics
  • Agilent Technologies
  • Danaher
  • Merck KGaA
  • Genapsys
  • Element Biosciences
  • Hamilton
  • Promega
  • Takara Bio
  • Bio-Rad Laboratories
  • Standard BioTools
  • Revvity
  • New England Biolabs
  • SomaLogic

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Nanopore Sequencing Market Overview
2.1. Nanopore Sequencing Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Nanopore Sequencing Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Nanopore Sequencing Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Nanopore Sequencing Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
5.2. Nanopore Sequencing Market Analysis By Technology, 2025-2034
5.2.1. Biological Nanopores
5.2.2. Solid-state Nanopores
5.2.3. Hybrid Nanopores
5.3. Nanopore Sequencing Market Analysis By Product Type, 2025-2034
5.3.1. Instruments
5.3.2. Consumables
5.3.3. Software & Services
5.4. Nanopore Sequencing Market Analysis By Application, 2025-2034
5.4.1. Clinical Diagnostics
5.4.2. Human Genomics
5.4.3. Oncology & Precision Medicine
5.4.4. Plant & Animal Genomics
5.4.5. Infectious-disease Surveillance
5.4.6. Drug Development & Pharmacogenomics
5.4.7. Food Safety & Environmental Monitoring
5.5. Nanopore Sequencing Market Analysis By End User, 2025-2034
5.5.1. Hospitals & Diagnostic Centers
5.5.2. Academic & Research Institutes
5.5.3. Pharmaceutical & Biotechnology Companies
5.5.4. Public-health Agencies
5.5.5. Agrigenomics & Veterinary Labs
6. North America Nanopore Sequencing Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Nanopore Sequencing Market Analysis By Technology
6.3. North America Nanopore Sequencing Market Analysis By Product Type
6.4. North America Nanopore Sequencing Market Analysis By Application
6.5. North America Nanopore Sequencing Market Analysis By End User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Nanopore Sequencing Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Nanopore Sequencing Market Analysis By Technology
7.3. Europe Nanopore Sequencing Market Analysis By Product Type
7.4. Europe Nanopore Sequencing Market Analysis By Application
7.5. Europe Nanopore Sequencing Market Analysis By End User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Nanopore Sequencing Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Nanopore Sequencing Market Analysis By Technology
8.3. Asia-Pacific Nanopore Sequencing Market Analysis By Product Type
8.4. Asia-Pacific Nanopore Sequencing Market Analysis By Application
8.5. Asia-Pacific Nanopore Sequencing Market Analysis By End User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Nanopore Sequencing Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Nanopore Sequencing Market Analysis By Technology
9.3. Middle East and Africa Nanopore Sequencing Market Analysis By Product Type
9.4. Middle East and Africa Nanopore Sequencing Market Analysis By Application
9.5. Middle East and Africa Nanopore Sequencing Market Analysis By End User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Nanopore Sequencing Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Nanopore Sequencing Market Analysis By Technology
10.3. South and Central America Nanopore Sequencing Market Analysis By Product Type
10.4. South and Central America Nanopore Sequencing Market Analysis By Application
10.5. South and Central America Nanopore Sequencing Market Analysis By End User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Nanopore Sequencing Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Oxford Nanopore Technologies
11.2.2. Pacific Biosciences
11.2.3. Illumina
11.2.4. Thermo Fisher Scientific
11.2.5. Roche
11.2.6. QIAGEN
11.2.7. BGI Genomics
11.2.8. Agilent Technologies
11.2.9. Danaher
11.2.10. Merck KGaA
11.2.11. Genapsys
11.2.12. Element Biosciences
11.2.13. Hamilton
11.2.14. Promega
11.2.15. Takara Bio
11.2.16. Bio-Rad Laboratories
11.2.17. Standard BioTools
11.2.18. Revvity
11.2.19. New England Biolabs
11.2.20. SomaLogic
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Illumina
  • Thermo Fisher Scientific
  • Roche
  • QIAGEN
  • BGI Genomics
  • Agilent Technologies
  • Danaher
  • Merck KGaA
  • Genapsys
  • Element Biosciences
  • Hamilton
  • Promega
  • Takara Bio
  • Bio-Rad Laboratories
  • Standard BioTools
  • Revvity
  • New England Biolabs
  • SomaLogic

Table Information